Connect with us
Thursday,03-September-2026
Breaking News

Business

Biocon Q4 results: Consolidated revenue growth recorded at Rs 2,476 Cr, up by 21%

Published

on

 Biocon registered total revenues at Rs 2,476 crore for the Quarter 4 of the financial year 2022. It also recorded net profit for the period at Rs 239 crore, as per the official statement released on Thursday late night.

During the year-ago period, the Bengaluru-based biopharma giant reported a net profit of Rs 253 crore on revenue of Rs 2,048 crore.

The company recorded a decline of 6 per cent compared to Q4 of last year and 12 per cent decline in comparison with the financial year 2021. The 2021 net profit stood at Rs 740 crore. The figures for 2022 stood at Rs 648 crore, as per the official statement.

The company stated that former HSBC India Chairperson Naina Lal Kidwai has been appointed as Additional Director on the Board of Biocon Ltd.

Commenting on the results, Kiran Mazumdar-Shaw, Executive Chairperson, Biocon and Biocon Biologics, said: “FY22 was a transformational year for Biocon. Key strategic moves in our Biosimilars business position us for long-term growth and value creation for our stakeholders.

“We believe that the two strategic transactions, with Viatris and Serum Institute Life Sciences, will position Biocon Biologics as a world leading, unique, fully integrated biologics company with a strong differentiated portfolio of biosimilars and vaccines.

“We reported a strong consolidated revenue growth of 21 per cent for Q4FY22 at Rs 2,476 crore driven by 48 per cent growth in Biosimilars, 26 per cent in Generics and 15 per cent in Research Services businesses.

“Our Gross R and D spends increased by 70 per cent this quarter to Rs 232 crore reflecting our advancing pipeline that will drive our future growth. Core EBITDA was up by 37 per cent at Rs 815 crore, representing healthy operating margins of 33 per cent. PBT before Exceptional Items stood at Rs 384 crore, up by 9 per cent.

On a full- year basis, we delivered consolidated revenue of US$ 1.1 billion (Rs 8,397 crore) and reported a Core EBITDA growth of 18 per cent at Rs 2,669 crore with core EBITDA margins at 32 per cent,” she explained.

Commenting on the performance, Dr Arun Chandavarkar, Managing Director, Biocon Biologics Ltd. said: “The 48 per cent (Y-o-Y) growth in revenues this quarter was a result of improved performance across developed and emerging markets, driven by strong market share gains of our interchangeable Glargine in the US. The health of our operational and business performance is reflected in the Core EBITDA margins being 39 per cent of revenues and growing 78 per cent Y-o-Y.

“We have progressed well in the development of several next wave biosimilar programmes, with two of our molecules entering the clinic. Whilst net R and D was at 9 per cent of revenues in FY22, we expect this to ramp up in FY23 commensurate with the progress of our rich and diverse pipeline which provides Biocon Biologics a sustainable growth opportunity in the years ahead.

The two strategic transactions with Serum and Viatris announced in FY22, upon likely closure in the second half of calendar year 2022, will propel us on our path to be a leading vertically integrated biosimilars company globally and will also support the higher investments in developing our pipeline,” he said.

Commenting on the Generics segment performance, Siddharth Mittal, CEO and Managing Director, Biocon Limited, said, “The business saw robust sequential as well as YoY growth in Q4, on the back of contributions from new product launches in the US, particularly Everolimus, an uptick in our API business and a normalisation of supply challenges that impacted us in the first half of the fiscal.

“However, our FY22 performance was muted, largely due to supply and operational challenges earlier in the year, as well as headwinds in the form of pricing pressures, and escalating costs of solvents, raw material and logistics.

“As we progress on our mission of providing high quality affordable medicines to patients around the globe, we will continue to focus on expediting our product pipeline, operationalising new capacities, and accelerating projects that drive cost and operational efficiencies across the organization.

“We will also commence work on important new projects in the current fiscal – a large scale synthetic facility in Hyderabad and an injectable facility in Bangalore; as well as expand our fermentation capacities in Bangalore, all of which will provide further impetus to our future growth.”

Jonathan Hunt, CEO & Managing Director, Syngene said: “I am pleased with the strong finish we had to the year and that we delivered results at the high end of our upgraded guidance range.

“Reflecting on the last two years of the pandemic, I am extremely proud of our track record: we created more than 2000 new jobs – more than in any other two-year period of the company’s history – and gained more than 100 new clients in the last year. We also extended and expanded our long-term partnership with Amgen Inc. and continued to invest in new capacity and technology to underpin future growth.

“Looking ahead, we see growing demand for research, development and manufacturing services around the world and we are well-positioned to take advantage of these new opportunities.”

Business

Why Nvidia chief Jensen Huang is not ready to retire?

Published

on

Chapel Hill (North Carolina), Sep 3: Nvidia Chief Executive Jensen Huang says he does not need to keep working.

He simply cannot bear the thought of missing what artificial intelligence (AI) could deliver over the next decade.

“I’ve been working a long time and Surely I don’t have to work, but I don’t want to miss, I’m definitely not going to miss the next 10, 15 years,” Huang said during a fireside chat with US Commerce Secretary Howard Lutnick.

For Huang, the appeal lies not only in the technology but also in the scale of the ambitions it has unleashed.

“The ambition of the industry, the ambition of my colleagues, my own ambition has really been supercharged,” he said.

Huang offered a buoyant vision of an AI-powered future in which work that once took a decade could be completed in a year, while year-long projects could be finished within a month.

“What do I expect in the next five, ten years? Things that take ten years are going to take one. Things that take one will take a month,” he added.

The Nvidia Chief said that artificial intelligence was giving ordinary people, companies and countries the ability to tackle problems on a scale previously considered unimaginable.

“It is now possible for average humans like ourselves to think that we can make an impact on a hundred trillion dollar industry,” Huang added.

He said that innovators were talking about adding between $20 trillion and $50 trillion in economic benefits worldwide.

Such ideas, he added, reflected a new level of ambition made possible by access to AI.

“No time in history have we been able to say things like that,” he said.

Huang encouraged countries to approach the technology with optimism and raise their ambitions rather than allow uncertainty to dominate the public conversation.

“This is the time when you have to feel enlightened, inspired, supercharged, lifted, because you now have this incredible technology behind you,” he said.

He compared the development of AI with earlier technological advances that initially appeared almost magical.

“Electricity once made it possible to turn on a light from far away, while modern cars and aircraft became safer as their technology improved.”

AI, Huang said, would similarly advance through engineering, mathematics, software and responsible development.

He rejected predictions that the technology would simply remove human workers.

AI would automate certain skills and tasks, he said, but people would retain the purpose, context and meaning that define their jobs.

Huang also described AI as a great equaliser because people could now communicate with computers through ordinary human language.

Lutnick picked up that theme, suggesting that the technology could place advanced knowledge within everyone’s reach.

“You now can have… A PhD in everything. That’s right. At your fingertips,” Lutnick said.

“You are that person now. Right? Everybody is that person now,” Huang responded.

Lutnick praised Huang’s optimistic assessment and called him “an American treasure”, saying Nvidia was leading the United States towards a future once confined largely to science fiction.

“Your company is leading us in a path that none of us, when we were young, ever dreamed possible,” the US Commerce Secretary said.

Huang co-founded Nvidia in 1993 and has served as its President and Chief Executive since its inception.

The company began as a specialist in graphics technology before its processors became vital to the development and operation of modern artificial intelligence systems.

Born in Taiwan, Huang moved to the United States as a child and studied electrical engineering at Oregon State University and Stanford University.

Under his leadership, Nvidia has grown into one of the world’s most valuable technology companies.

Continue Reading

Business

Indian markets open higher amid positive global cues, easing US yields

Published

on

Mumbai, Sep 3: Indian equity benchmarks opened higher on Thursday tracking positive global cues and gains in Asian markets.

Sensex opened 154.60 points or 0.20 per cent higher at 76,724.95, while Nifty gained 83.50 points or 0.35 per cent to 23,997.95.

In early trade, banking and realty stocks led sectoral gains as Nifty PSU Bank and Nifty Realty gained up to 1 per cent.

Meanwhile, Nifty Private Bank climbed 0.83 per cent and Nifty MidSmall Financial Services index advanced 0.82 per cent.

On the other hand, Nifty IT fell 0.8 per cent, while Nifty FMCG dropped 0.44 per cent and Nifty Healthcare, Nifty Pharma and Nifty500 Healthcare were also marginally lower.

According to market experts, sentiment was likely to improve following a slight easing in US bond yields.

They said the mobilisation of $136 billion under a concessional swap facility, including $127 billion through the FCNR(B) scheme could support the rupee and improve foreign investor confidence.

The large FCNR(B) mobilisation by banks could also help improve net interest margins, providing support to banking stocks, they said.

They noted that Wednesday’s 141-point decline in Nifty came despite institutional buying of about Rs 9,500 crore comprising Rs 6,688 crore from foreign institutional investors and Rs 2,812 crore from domestic institutional investors.

“This suggested that selling pressure had largely come from retail investors, proprietary traders and bears,” according to the experts.

Technical analysts said the rebound from around 23,800 had strengthened expectations of a move higher, although they remained cautious about chasing prices. A break above the 24,150-24,215 zone would signal further strength, while 23,860 was seen as an important downside marker.

Additionally, Asian equities broadly mirrored gains on Wall Street. In addition, crude oil prices edged lower after US President Donald Trump downplayed the likelihood of an extended conflict with Iran.

Continue Reading

Business

Meta launches ‘Muse Voice Transcribe’ with native support for five Indian languages

Published

on

New Delhi, Sep 2: US-based technology giant Meta has introduced its first real‑time audio‑perception model — Muse Voice Transcribe — which offers native support for five major Indian languages and advanced streaming features.

Muse Voice Transcribe — developed by Meta Superintelligence Labs — delivers streaming transcription, speaker separation across over 20 voices in hour‑plus recordings, native code‑switching and diarisation from a single model with no post‑processing step, the company said in a statement.

Muse Voice Transcribe is trained across over 70 languages spoken in multiple countries with 25 validated at launch.

“It ranks first on the Artificial Analysis streaming speech-to-text leaderboard as of September 1, 2026,” the statement added.

Available via the Meta Model API and already running dictation in Meta AI for Mac and Muse Code, Muse Voice Transcribe delivers real‑time automatic speech recognition, diarisation with over 20 speakers and endpointing.

It is multilingual with seamless code-switching and improves accuracy with language, keyword, and context biasing.

“The longer the model waits to predict, the more accurate the transcript, but the higher the latency. Muse Voice Transcribe has “adaptive delay,” dynamically changing delay for each word based on difficulty,” the statement noted.

This is enabled with reinforcement learning (RL), where word error rate (WER) reward and a delay reward are combined multiplicatively.

“Muse Voice Transcribe is an autoregressive multimodal model from the Muse Spark family,” Meta said.

It explained that the audio is processed in 80 ms chunks (12.5 Hz), each of which is transformed into a single soft token. At each audio chunk, the model decides to either continue listening to the next audio chunk or emit a text token.

With adaptive delay, Muse Voice Transcribe achieves the Pareto front on speed-accuracy trade-off measured by time to final transcription, the company said.

Continue Reading

Trending